右羟吗喃结构式
|
常用名 | 右羟吗喃 | 英文名 | DEXTRORPHAN D-TARTRATE |
|---|---|---|---|---|
| CAS号 | 125-73-5 | 分子量 | 407.45700 | |
| 密度 | 1.17g/cm3 | 沸点 | 410.4ºC at 760mmHg | |
| 分子式 | C21H29NO7 | 熔点 | ≥195ºC | |
| MSDS | 中文版 美版 | 闪点 | 207.2ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
| 中文名 | 右羟吗喃 |
|---|---|
| 英文名 | dextrorphan |
| 中文别名 | 右啡烷 | 右美沙芬杂质B |
| 英文别名 | 更多 |
| 密度 | 1.17g/cm3 |
|---|---|
| 沸点 | 410.4ºC at 760mmHg |
| 熔点 | ≥195ºC |
| 分子式 | C21H29NO7 |
| 分子量 | 407.45700 |
| 闪点 | 207.2ºC |
| 精确质量 | 407.19400 |
| PSA | 138.53000 |
| LogP | 0.89570 |
| InChIKey | JAQUASYNZVUNQP-PVAVHDDUSA-N |
| SMILES | CN1CCC23CCCCC2C1Cc1ccc(O)cc13 |
| 蒸汽压 | 0mmHg at 25°C |
| 折射率 | 1.621 |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:5 3.氢键受体数量:8 4.可旋转化学键数量:3 5.互变异构体数量:3 6.拓扑分子极性表面积139 7.重原子数量:29 8.表面电荷:0 9.复杂度:491 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:5 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
| 更多 | 1.性状:白色类白色结晶。 2.熔点(℃):≥195。 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xn: Harmful; |
| 风险声明 (欧洲) | 22 |
| 危险品运输编码 | NONH for all modes of transport |
| RTECS号 | QD1832000 |
| 右羟吗喃上游产品 0 | |
|---|---|
| 右羟吗喃下游产品 1 | |
|
Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device.
Xenobiotica 45(1) , 29-44, (2014) 1. The quantitative prediction of the pharmacokinetic parameters of a drug from data obtained using human in vitro systems remains a significant challenge i.e. prediction of metabolic clearance in hum... |
|
|
Evaluation of thein vitro/in vivodrug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition
Food Chem. Toxicol. 68 , 117-27, (2014) • BST204 is a purified dry extract of ginseng containing high amounts of Rh2 and Rg3. • BST204 had only weak inhibitory effects on nine CYPs and five UGTs. • It is unlikely that BST204 alter pharmacok... |
|
|
Determination of sitafloxacin in human plasma by liquid chromatography–tandem mass spectrometry method: Application to a pharmacokinetic study
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 957 , 36-40, (2014) • An LC–MS/MS method has been developed for determining sitafloxacin in human plasma. • The method has some merits: high sensitivity, small sample volume and short runtime. • It is successfully applie... |
| (+)-3-hydroxy-N-methylmorphinan |
| Dextro-Dromoran |
| D-3-hydroxy-N-methylmorphinan |
| DEXTRORPHAN D-TARTRATE |
| MFCD00864199 |
| d-Form of levorphanol |
| O-Demethyl dextromethorphan |
| d-Levorphanol |
| (+)-N-Methylmorphinan-3-ol |
| Racemorphan |
| EINECS 204-754-3 |
| Dextrorphane |